PTC Therapeutics, Inc.

PTCT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001070081

SEC filings (opens in a new tab)

In the last 90 days, PTC Therapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 382 institutions reported holding it in 13F filings for Q2 2026, worth $8.20B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding PTC Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of PTCT: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Of which not filed for Q3 2022	Q3 2022	Change
Holders	182	1	213	+32
Shares	74.1M	12	76.3M	+2.14M (+2.9%)
Value	$2.97B	$481	$3.83B	+$857.1M (+28.8%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (50)

Institutions that held PTC Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PTCT in Q3 2022
Institution	Shares	Value	% of portfolio
Millennium Management LLC	441,353	$22.2M	0.03%
Two Sigma Investments, LP	307,156	$15.4M	0.05%
Two Sigma Advisers, LP	273,042	$13.7M	0.04%
T. Rowe Price Investment Management, Inc.	248,299	$12.5M	0.01%
Susquehanna Fundamental Investments, LLC	126,488	$6.35M	0.11%
Voloridge Investment Management, LLC	102,299	$5.13M	0.03%
Hillsdale Investment Management Inc.	100,337	$5.04M	0.46%
Teachers Retirement System of the State of Kentucky	98,530	$4.95M	0.06%
Federated Hermes, Inc.	72,477	$3.64M	0.01%
Phocas Financial Corp.	69,936	$3.51M	0.54%
Fred Alger Management, LLC	56,308	$2.83M	0.01%
Qube Research & Technologies Ltd	41,654	$2.09M	0.01%
Putnam Investments LLC	38,694	$1.94M	0.00%
Duality Advisers, LP	35,157	$1.76M	0.19%
Canada Pension Plan Investment Board	33,500	$1.68M	0.00%
Natixis	25,000	$1.25M	0.01%
HRT Financial LP	21,060	$1.06M	0.01%
Neuberger Berman Group LLC	16,364	$821.0K	0.00%
Dimensional Fund Advisors LP	15,593	$783.0K	0.00%
Aquatic Capital Management LLC	12,800	$643.0K	0.06%
Virginia Retirement Systems Et Al	12,000	$602.4K	0.01%
Dynamic Technology Lab Private Ltd	11,550	$580.0K	0.06%
Aigen Investment Management, LP	10,664	$535.0K	0.08%
Quantamental Technologies LLC	7,403	$372.0K	0.14%
Vise Technologies, Inc.	6,772	$340.0K	0.13%
Occudo Quantitative Strategies LP	6,540	$328.0K	0.03%
Renaissance Technologies LLC	5,600	$281.0K	0.00%
Zebra Capital Management LLC	5,331	$268.0K	1.02%
Envestnet Asset Management Inc	5,183	$260.0K	0.00%
Nadler Financial Group, Inc.	4,939	$248.0K	0.05%
Seven Eight Capital, LP	4,945	$248.0K	0.05%
Mackenzie Financial Corp	4,761	$239.0K	0.00%
Prelude Capital Management, LLC	4,609	$231.0K	0.01%
Stifel Financial Corp	4,152	$208.0K	0.00%
Kennedy Capital Management, Inc.	4,088	$205.0K	0.01%
Acadian Asset Management LLC	1,361	$68.0K	0.00%
Focused Wealth Management, Inc	1,200	$60.0K	0.01%
Lazard Asset Management LLC	1,152	$57.0K	0.00%
China Universal Asset Management Co., Ltd.	670	$34.0K	0.01%
Altshuler Shaham Ltd	496	$25.0K	0.00%
Quantbot Technologies LP	200	$10.0K	0.00%
Group One Trading, L.P.	173	$9.00K	0.00%
Contravisory Investment Management, Inc.	108	$5.00K	0.00%
Ronald Blue Trust, Inc.	51	$2.00K	0.00%
Allworth Financial LP	29	$1.00K	0.00%
JFS Wealth Advisors, LLC	6	$0	0.00%
Ellevest, Inc.	1	$0	0.00%
Disciplined Investments, LLC	3	$0	0.00%
SJS Investment Consulting Inc.	1	$0	0.00%
Schubert & Co	4	$0	0.00%

Sold out (18)

Institutions that held PTC Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PTCT in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Walleye Capital LLC	60,412	$2.42M
Graham Capital Management, L.P.	54,001	$2.16M
CM Management, LLC	45,000	$1.80M
Man Group plc	–	$1.24M
Allianz Asset Management GmbH	18,495	$741.0K
SG Americas Securities, LLC	12,214	$489.0K
Gsa Capital Partners LLP	11,002	$441.0K
Simplex Trading, LLC	8,427	$337.0K
1623 Capital LLC	8,335	$334.0K
Spearhead Capital Advisors, LLC	7,448	$298.0K
CenterBook Partners LP	6,845	$274.0K
Virtu Financial LLC	6,589	$264.0K
Caption Management, LLC	5,000	$200.0K
Neo Ivy Capital Management	2,969	$118.0K
Gladius Capital Management LP	598	$24.0K
MayTech Global Investments, LLC	145	$6.00K
Captrust Financial Advisors	112	$4.00K
Elequin Capital LP	27	$1.00K

Not filed for Q3 2022 yet (1)

Institutions that held PTC Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PTCT in Q2 2022 that haven't filed for Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Exane Derivatives	12	$481